South America CIN & HR-HPV Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)

No. of Pages: 97    |    Report Code: BMIRE00028591    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America CIN & HR-HPV Treatment Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South America CIN & HR-HPV Market – by Disease Type

1.3.2        South America CIN & HR-HPV Market – by Strain Type

1.3.3        South America CIN & HR-HPV Market – by Offering

1.3.4        South America CIN & HR-HPV Market – by Product Type

1.3.5        South America CIN & HR-HPV Market – by End User

1.3.6        South America CIN & HR-HPV Market – by Country

2.           CIN & HR-HPV Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South America CIN & HR-HPV Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        4.2.1 South America PEST Analysis

4.3         Expert’s Opinion

5.           South America CIN & HR-HPV Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of Human Papillomavirus Infections

5.1.2        Favorable Initiatives for Preventing Cervical Cancer

5.2         Market Restraints

5.2.1        Increased Reoccurrence Rate and High Cost of CIN & HR-HPV Treatment

5.3         Market Opportunities

5.3.1        Development and Launch of Innovative Products

5.4         Future Trends

5.4.1        Use of Modern Technologies in CIN & HR-HPV Screening and Diagnosis

5.5         Impact Analysis

6.           CIN & HR-HPV Market – South America Analysis

6.1         South America CIN & HR-HPV Market Revenue Forecast and Analysis

7.           South America CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028– by Disease Type

7.1         Overview

7.2         South America CIN and HR-HPV Treatment Market, By disease type, 2022 & 2028 (%)

7.3         CIN 1

7.3.1        Overview

7.3.2        CIN 1: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

7.4         CIN 2

7.4.1        Overview

7.4.2        CIN 2: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

7.5         CIN 3

7.5.1        Overview

7.5.2        CIN 3: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.           South America CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028– by Strain Type

8.1         Overview

8.2         South America CIN and HR-HPV Treatment Market, By Strain Type, 2022 & 2028 (%)

8.3         HPV 16

8.3.1        Overview

8.3.2        HPV 16: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.4         HPV 18

8.4.1        Overview

8.4.2        HPV 18: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.           South America CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028– by Offering

9.1         Overview

9.2         South America CIN and HR-HPV Treatment Market, By Offering, 2022 & 2028 (%)

9.4         Diagnostic Method

9.4.1        Overview

9.4.2        Diagnostic Method: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.3        Pap Smear

9.4.3.1          Overview

9.4.3.2          Pap Smear: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.4        HPV Testing

9.4.4.1          Overview

9.4.4.2          HPV Testing: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5        Colposcopy

9.4.5.1          Overview

9.4.5.2          Colposcopy: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.6        Biopsy

9.4.6.1          Overview

9.4.6.2          Biopsy: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5         Treatment

9.5.1        Overview

9.5.2        Treatment: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5.2.1          Excision Surgery

9.5.2.1.1          Overview

9.5.2.1.2          Excision Surgery: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5.2.2          Ablation Techniques

9.5.2.2.1          Overview

9.5.2.2.2          Ablation Techniques: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.        South America CIN & HR-HPV Treatment Market Analysis and Forecast to 2028 – by Product Type

10.1      Overview

10.2      South America CIN & HR-HPV Treatment Market, by Product Type 2022 & 2028 (%)

10.3      Kits & Reagents

10.3.1     Overview

10.3.2     Kits & Reagents: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Instrument

10.4.1     Overview

10.4.2     Instrument: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Services

10.5.1     Overview

10.5.2     Services: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.        South America CIN & HR-HPV Treatment Market Analysis and Forecast to 2028 – by End User

11.1      Overview

11.2      South America CIN & HR-HPV Treatment Market, by End User 2022 & 2028 (%)

11.3      Hospital & Clinics

11.3.1     Overview

11.3.2     Hospital & Clinics: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.4      Diagnostic Laboratories

11.4.1     Overview

11.4.2     Diagnostic Laboratories: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.5      Specialized Clinical Laboratories

11.5.1     Overview

11.5.2     Specialized Clinical Laboratories: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.6      Others

11.6.1     Overview

11.6.2     Others: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.        South America CIN & HR-HPV Treatment Market Revenue and Forecasts to 2028 – Country Analysis

12.1      South America CIN & HR-HPV Market

12.1.1     Overview

12.1.1.1       Argentina: CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.1       Overview

12.1.1.1.2       Argentina CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.3       Argentina CIN and HR-HPV Treatment Market, by Disease Type, 2019–2028 (US$ Million)

12.1.1.1.4       Argentina CIN and HR-HPV Treatment Market, by Strain Type, 2019–2028 (US$ Million)

12.1.1.1.5       Argentina CIN and HR-HPV Treatment Market, by Offerings, 2019–2028 (US$ Million)

12.1.1.1.5.1     Argentina: CIN and HR-HPV Treatment Market, by Diagnostic Methods, 2019–2028 (US$ Million)

12.1.1.1.5.2     Argentina: CIN and HR-HPV Treatment Market, by Treatments, 2019–2028 (US$ Million)

12.1.1.1.6       Argentina CIN and HR-HPV Treatment Market, by Product Type, 2019–2028 (US$ Million)

12.1.1.1.7       Argentina CIN and HR-HPV Treatment Market, by End Users, 2019–2028 (US$ Million)

12.1.1.2       Brazil: CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.1       Overview

12.1.1.2.2       Brazil CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.3       Brazil CIN and HR-HPV Treatment Market, by Disease Type, 2019–2028 (US$ Million)

12.1.1.2.4       Brazil CIN and HR-HPV Treatment Market, by Strain Type, 2019–2028 (US$ Million)

12.1.1.2.5       Brazil CIN and HR-HPV Treatment Market, by Offerings, 2019–2028 (US$ Million)

12.1.1.2.5.1     Brazil: CIN and HR-HPV Treatment Market, by Diagnostic Methods, 2019–2028 (US$ Million)

12.1.1.2.5.2     Brazil: CIN and HR-HPV Treatment Market, by Treatments, 2019–2028 (US$ Million)

12.1.1.2.6       Brazil CIN and HR-HPV Treatment Market, by Product Type, 2019–2028 (US$ Million)

12.1.1.2.7       Brazil CIN and HR-HPV Treatment Market, by End Users, 2019–2028 (US$ Million)

12.1.1.3       Rest of South America: CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.1       Overview

12.1.1.3.2       Rest of South America CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.3       Rest of South America CIN and HR-HPV Treatment Market, by Disease Type, 2019–2028 (US$ Million)

12.1.1.3.4       Rest of South America CIN and HR-HPV Treatment Market, by Strain Type, 2019–2028 (US$ Million)

12.1.1.3.5       Rest of South America CIN and HR-HPV Treatment Market, by Offerings, 2019–2028 (US$ Million)

12.1.1.3.5.1     Rest of South America: CIN and HR-HPV Treatment Market, by Diagnostic Methods, 2019–2028 (US$ Million)

12.1.1.3.5.2     Rest of South America: CIN and HR-HPV Treatment Market, by Treatments, 2019–2028 (US$ Million)

12.1.1.3.6       Rest of South America CIN and HR-HPV Treatment Market, by Product Type, 2019–2028 (US$ Million)

12.1.1.3.7       Rest of South America CIN and HR-HPV Treatment Market, by End Users, 2019–2028 (US$ Million)

13.        South America CIN & HR-HPV Treatment Market – Industry Landscape

13.1      Overview

13.2      Growth Strategies in CIN & HR-HPV Treatment Market

13.3      Organic Growth Strategies

13.3.1     Overview

13.4      Inorganic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      Fujirebio Europe NV

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     .Key Developments

14.2      Qiagen NV

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Abbott Laboratories

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      F. Hoffmann-La Roche Ltd

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Thermo Fisher Scientific Inc

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Argentina CIN and HR-HPV Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Argentina CIN and HR-HPV Treatment Market, by Strain Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Argentina CIN and HR-HPV Treatment Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Argentina CIN and HR-HPV Treatment Market, by Diagnostic Methods – Revenue and Forecast to 2028 (US$ Million

Table 5.             Argentina CIN and HR-HPV Treatment Market, by Treatments – Revenue and Forecast to 2028 (US$ Million

Table 6.             Argentina CIN and HR-HPV Treatment Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina CIN and HR-HPV Treatment Market, by End Users – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Brazil CIN and HR-HPV Treatment Market, by Disease type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Brazil CIN and HR-HPV Treatment Market, by Strain Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Brazil CIN and HR-HPV Treatment Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Brazil CIN and HR-HPV Treatment Market, by Diagnostic Methods – Revenue and Forecast to 2028 (US$ Million

Table 12.          Brazil CIN and HR-HPV Treatment Market, by Treatments – Revenue and Forecast to 2028 (US$ Million

Table 13.          Brazil CIN and HR-HPV Treatment Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Brazil CIN and HR-HPV Treatment Market, by End Users – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of South America CIN and HR-HPV Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of South America CIN and HR-HPV Treatment Market, by Strain Type – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of South America CIN and HR-HPV Treatment Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of South America CIN and HR-HPV Treatment Market, by Diagnostic Methods – Revenue and Forecast to 2028 (US$ Million

Table 19.          Rest of South America CIN and HR-HPV Treatment Market, by Treatments – Revenue and Forecast to 2028 (US$ Million

Table 20.          Rest of South America CIN and HR-HPV Treatment Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of South America CIN and HR-HPV Treatment Market, by End Users – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Recent Organic Growth Strategies in CIN & HR-HPV Treatment Market

Table 23.          Recent Inorganic Growth Strategies in the CIN & HR-HPV Treatment Market

Table 24.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           South America CIN & HR-HPV Market Segmentation

Figure 2.           South America CIN & HR-HPV Market, by Country

Figure 3.           South America CIN & HR-HPV Market Overview

Figure 4.           Cervical Intraepithelial Neoplasia 3 Segment Held Largest Share of Disease Type Segment in CIN & HR-HPV Market

Figure 5.           Brazil Expected to Show Remarkable Growth During Forecast Period

Figure 6.           South America: PEST Analysis

Figure 7.           South America Experts’ Opinion

Figure 8.           South America CIN & HR-HPV Market: Impact Analysis of Drivers and Restraints

Figure 9.           South America CIN & HR-HPV Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        South America CIN and HR-HPV Treatment Market, by disease type, 2022 & 2028 (%)

Figure 11.        CIN 1: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        CIN 2: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        CIN 3: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        South America CIN and HR-HPV Treatment Market, by Strain Type, 2022 & 2028 (%)

Figure 15.        HPV 16: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        HPV 18: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Others: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        South America CIN and HR-HPV Treatment Market, by offering, 2022 & 2028 (%)

Figure 19.        Diagnostic Method: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Pap Smear: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        HPV Testing: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Colposcopy: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Biopsy: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Treatment: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Excision Surgery: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Ablation Techniques: South America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        South America CIN & HR-HPV Treatment Market, by Product Type 2022 & 2028 (%)

Figure 28.        Kits & Reagents: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Instrument: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Services: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South America CIN & HR-HPV Treatment Market, by End User 2022 & 2028 (%)

Figure 32.        Hospital & Clinics: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Diagnostic Laboratories: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Specialized Clinical Laboratories: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: South America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        South America CIN and HR-HPV Treatment Market, by Key Country – Revenue (2022) (US$ Million)

Figure 37.        South America CIN and HR-HPV Treatment Market, by Country, 2022 & 2028 (%)

Figure 38.        Argentina CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Brazil CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Rest of South America CIN and HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Growth Strategies in CIN & HR-HPV Treatment Market

 

The List of Companies - South America CIN & HR-HPV Treatment Market

  1. Fujirebio Europe NV
  2. Qiagen NV
  3. Abbott Laboratories
  4. F. Hoffmann-LA Roche Ltd
  5. Thermo Fisher Scientific Inc